ATE234615T1 - Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren - Google Patents

Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren

Info

Publication number: ATE234615T1
Authority: AT; Austria
Prior art keywords: treatment; acetylcystone; production; ulcers; medicinal product
Prior art date: 1996-12-20

Application number

AT97310391T

Other languages

English (en)

Inventor

Stephen Bloor

Original Assignee

Johnson & Johnson Medical Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1997-12-19

Publication date

2003-04-15

1997-12-19 Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd

2003-04-15 Application granted granted Critical

2003-04-15 Publication of ATE234615T1 publication Critical patent/ATE234615T1/de

Links

208000025865 Ulcer Diseases 0.000 title abstract 3
238000011282 treatment Methods 0.000 title abstract 3
231100000397 ulcer Toxicity 0.000 title abstract 3
230000001684 chronic effect Effects 0.000 title abstract 2
229940126601 medicinal product Drugs 0.000 title 1
206010056340 Diabetic ulcer Diseases 0.000 abstract 1
PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 1
208000000558 Varicose Ulcer Diseases 0.000 abstract 1
229960004308 acetylcysteine Drugs 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT97310391T 1996-12-20 1997-12-19 Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren ATE234615T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9626468A GB2320431B (en)	1996-12-20	1996-12-20	Compositions for the treatment of chronic wounds

Publications (1)

Publication Number	Publication Date
ATE234615T1 true ATE234615T1 (de)	2003-04-15

Family

ID=10804743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97310391T ATE234615T1 (de)	1996-12-20	1997-12-19	Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren

Country Status (11)

Country	Link
US (1)	US6166084A (de)
EP (1)	EP0848951B1 (de)
JP (1)	JPH10273438A (de)
AT (1)	ATE234615T1 (de)
AU (1)	AU726545B2 (de)
CA (1)	CA2225202A1 (de)
CO (1)	CO4930267A1 (de)
DE (1)	DE69719931T2 (de)
GB (1)	GB2320431B (de)
SG (1)	SG63786A1 (de)
ZA (1)	ZA9711467B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1312088B1 (it) *	1999-04-21	2002-04-04	Altergon Sa	Cerotto per uso topico contenente eparina e diclofenac.
EP1609468A3 (de) *	2000-11-22	2006-01-25	Rxkinetix, Inc.	Eine Zusammensetzung auf der Basis eines Schwefel enthaltenden Antioxidans wie dessen Verwendung zur Herstellung eines Medikaments für die Behandlung von Mucositis
US6600057B2 (en)	2000-12-29	2003-07-29	Kimberly-Clark Worldwide, Inc.	Matrix metalloproteinase inhibitors
DE10121255A1 (de) *	2001-04-30	2002-11-07	Switch Biotech Ag	Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
WO2003015808A1 (en) *	2001-08-16	2003-02-27	Hnat Thomas M	Method and composition for treatment of wounds and burns
SE522979C2 (sv) *	2002-07-03	2004-03-23	Moelnlycke Health Care Ab	Sårförband innefattande en icke-enzymatisk antioxidant
CA2529236A1 (en) *	2004-12-07	2006-06-07	Centre Des Technologies Textiles	New antimicrobial material
WO2007137000A2 (en) *	2006-05-16	2007-11-29	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Combination cancer chemotherapy
US20090131303A1 (en) *	2007-11-16	2009-05-21	Bor-Shyue Hong	Methods and compositions for treating dry eye
US20090177133A1 (en) *	2008-01-04	2009-07-09	Kristine Kieswetter	Reduced pressure dressing coated with biomolecules
US20100022652A1 (en) *	2008-07-28	2010-01-28	Tyco Healthcare Group Lp	Antimicrobial and Anticoagulant Compositions and Methods
GB2470040A (en)	2009-05-06	2010-11-10	Systagenix Wound Man Ip Co Bv	Wound dressing material comprising N-acetyl cysteine
EP2445483B1 (de) *	2009-06-25	2017-04-26	McCord, Darlene	Topische zusammensetzungen und verfahren zur wundpflege
US8632512B2 (en)	2010-04-09	2014-01-21	Kci Licensing, Inc.	Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US9999702B2 (en)	2010-04-09	2018-06-19	Kci Licensing Inc.	Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
EP2397125A1 (de) *	2010-06-15	2011-12-21	Histocell, S.L.	Antioxidationszusammensetzung
EP3536337A1 (de)	2010-09-22	2019-09-11	The Regents of the University of Colorado, a body corporate	Therapeutische anwendungen von smad7
US8597264B2 (en)	2011-03-24	2013-12-03	Kci Licensing, Inc.	Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US10456448B2 (en)	2013-03-08	2019-10-29	The Regents Of The University Of Colorado, A Body Corporate	PTD-SMAD7 therapeutics
EP2976095B1 (de)	2013-03-15	2020-12-23	3M Innovative Properties Company	Zusammensetzungen zur wundheilung
JP6521995B2 (ja)	2014-02-20	2019-05-29	ユニヴァーシティーオブノートルダムデュラック	選択的マトリックスメタロプロテイナーゼ阻害剤
US10357546B2 (en)	2014-09-19	2019-07-23	University Of Notre Dame Du Lac	Acceleration of diabetic wound healing
MX2017004520A (es)	2014-10-14	2018-03-15	Lynch Samuel	Composiciones para tratar heridas.
US10299503B2 (en) *	2017-01-24	2019-05-28	Recommended By Mom Llc	N-acetyl cysteine based compositions
US10292998B1 (en)	2018-08-07	2019-05-21	Ahad Mahootchi	Compositions and methods for prevention and treatment of eye infections
MX2022002760A (es)	2019-09-06	2022-04-06	Consejo Nacional De Investigaciones Cientificas Y Tecn	Una composicion farmaceutica para el tratamiento topico de heridas.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1154914A (en) *	1965-08-26	1969-06-11	Mead Johnson & Co	Anti-Inflammatory Compositions and methods
ZA702518B (en) *	1969-04-18	1971-01-27	Bristol Myers Co	Acetylcysteine for acne
US3749770A (en) *	1969-08-11	1973-07-31	Mead Johnson & Co	Compositions containing zinc mercaptide n-acetylcysteine carboxylate salts
US4276284A (en) *	1971-07-26	1981-06-30	Brown Stuart I	Prevention of collagenase induced disease by treatment with collagenase inhibitors
FR2519988B1 (fr) *	1982-01-20	1985-06-14	Refarmed Sa	Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
IT1194117B (it) *	1981-11-20	1988-09-14	Isnardi Pietro & C Spa	Derivati salicilici di n-acetilcisteina
US4414387A (en) *	1982-05-13	1983-11-08	Renato Broggi	Cephapirin acetylcysteinate having antibacterial activity
GB8517301D0 (en) *	1985-07-09	1985-08-14	Salim A S M	Synergistic biologically active substances
US4708965A (en) *	1985-09-16	1987-11-24	Morgan Lee R	Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
US4724239A (en) *	1985-09-16	1988-02-09	Morgan Lee R	Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
IL95393A0 (en) *	1989-08-18	1991-06-30	John Morris Co	Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
CA2164955A1 (en) *	1993-06-18	1995-01-05	Richard J. Sharpe	Method for treating hyperkeratosis and diseases mediated by proteases
DE4328871A1 (de) *	1993-08-27	1995-03-02	Beiersdorf Ag	Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis

1996
- 1996-12-20 GB GB9626468A patent/GB2320431B/en not_active Expired - Lifetime
1997
- 1997-12-15 AU AU48383/97A patent/AU726545B2/en not_active Ceased
- 1997-12-17 US US08/992,649 patent/US6166084A/en not_active Expired - Lifetime
- 1997-12-17 SG SG1997004499A patent/SG63786A1/en unknown
- 1997-12-18 CA CA002225202A patent/CA2225202A1/en not_active Abandoned
- 1997-12-19 AT AT97310391T patent/ATE234615T1/de not_active IP Right Cessation
- 1997-12-19 JP JP9365307A patent/JPH10273438A/ja active Pending
- 1997-12-19 ZA ZA9711467A patent/ZA9711467B/xx unknown
- 1997-12-19 EP EP97310391A patent/EP0848951B1/de not_active Expired - Lifetime
- 1997-12-19 DE DE69719931T patent/DE69719931T2/de not_active Expired - Lifetime
- 1997-12-22 CO CO97074402A patent/CO4930267A1/es unknown

Also Published As

Publication number	Publication date
US6166084A (en)	2000-12-26
SG63786A1 (en)	1999-03-30
GB9626468D0 (en)	1997-02-05
CO4930267A1 (es)	2000-06-27
GB2320431B (en)	2000-08-30
GB2320431A (en)	1998-06-24
JPH10273438A (ja)	1998-10-13
AU4838397A (en)	1998-06-25
GB2320431A8 (en)	1998-12-18
CA2225202A1 (en)	1998-06-20
DE69719931D1 (de)	2003-04-24
DE69719931T2 (de)	2003-12-24
EP0848951A1 (de)	1998-06-24
AU726545B2 (en)	2000-11-09
EP0848951B1 (de)	2003-03-19
ZA9711467B (en)	1999-09-20

Similar Documents

Publication	Publication Date	Title
ATE234615T1 (de)	2003-04-15	Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren
DE69636085D1 (de)	2006-06-08	Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea
DE69521620D1 (de)	2001-08-09	Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ATE205086T1 (de)	2001-09-15	Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
FI971420A0 (fi)	1997-04-04	Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä
AU697679B2 (en)	1998-10-15	Treatment of tinnitis using neuroprotective agents
ATE201597T1 (de)	2001-06-15	Verabreichung von riluzol zur behandlung von neuro-aids
DE69428325D1 (de)	2001-10-25	Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
ATE191849T1 (de)	2000-05-15	Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
ATE137965T1 (de)	1996-06-15	Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
DE68911891D1 (de)	1994-02-10	Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung.
ATE196738T1 (de)	2000-10-15	Verwendung von immunglobulin-präparationen zur herstellung eines medikaments zur oralen verabreichung zur behandlung und prophylaxe chronischer schmerzzustände
ATE119770T1 (de)	1995-04-15	Verwendung von acetyl l-carnitin zur therapeutischen behandlung von coma.
ATE180669T1 (de)	1999-06-15	Verwendung von pregnanderivaten zur behandlung von tumoren
DE69304843D1 (de)	1996-10-24	Methode zur Behandlung von Haarausfall
ATE252383T1 (de)	2003-11-15	Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE83480T1 (de)	1993-01-15	Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
HUP0001913A2 (hu)	2000-11-28	Pramipexole alkalmazása állandóan mozgó láb szindróma kezelésére szolgáló gyógyszerkészítmények előállítására
ATE183088T1 (de)	1999-08-15	Arzneimittel zur behandlung von hauterkrankungen
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
NO890801D0 (no)	1989-02-24	Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer.
ATE232723T1 (de)	2003-03-15	Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen
ATE234613T1 (de)	2003-04-15	Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
TR200003451T2 (tr)	2001-04-20	Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
AU8069891A (en)	1991-12-31	Novel alpha-glucosidase inhibitors

Legal Events

Date	Code	Title	Description
2003-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties